330 results on '"Middleton, Peter G"'
Search Results
2. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
3. Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
4. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
5. Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis
6. Standards for the care of people with cystic fibrosis; establishing and maintaining health
7. Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis
8. Obstructive sleep apnoea and sleep disorders in pregnancy
9. Pulmonary disorders in pregnancy: Bronchiectasis, cystic fibrosis, sarcoidosis and interstitial diseases
10. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
11. Transition to adult care in cystic fibrosis: The challenges and the structure
12. Survival of people with cystic fibrosis in Australia
13. Redesign of the Australian Cystic Fibrosis Data Registry: A multidisciplinary collaboration
14. Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
15. Standards for the care of people with cystic fibrosis; establishing and maintaining health
16. Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators – an international survey
17. Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio‐sampling of the lower airways in children and adults
18. Reflections 5 years on from the approval of ETI therapy.
19. Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry
20. A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy
21. Standards for the care of people with cystic fibrosis (CF)
22. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
23. A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy
24. La terapia con moduladores para la fibrosis quística puede revertir las bronquiectasias quísticas
25. Occupations and balance during the transition to motherhood with a lifetime chronic illness: A scoping review examining cystic fibrosis, asthma, and Type‐1 diabetes
26. Saline at lower tonicity in cystic fibrosis (SALTI-CF) trial comparing 0.9%versus3%versus6% nebulised saline
27. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
28. Mukoviszidose-Modulatortherapie kann zystische Bronchiektasen rückgängig machen
29. Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro
30. Cystic Fibrosis Related Diabetes: Potential pitfalls in the transition from paediatric to adult care
31. Cystic fibrosis modulator therapy can reverse cystic bronchiectasis.
32. Survival of People with Cystic Fibrosis in Australia
33. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
34. Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study
35. Rectal organoid morphometric analysis (ROMA)--re: optimising measurements automatically.
36. Timing of dornase alpha inhalation does not affect the efficacy of an airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial
37. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis
38. Family planning, pregnancy and birth in women with lung conditions: a worldwide survey
39. Azithromycin and tezacaftor/ivacaftor is associated with first-degree heart block in an adult with cystic fibrosis
40. Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation
41. COVID-19 vaccine prioritisation for people with cystic fibrosis
42. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
43. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
44. Australian standards of care for cystic fibrosis-related diabetes
45. Concerns regarding the safety of azithromycin in pregnancy - relevance for women with cystic fibrosis
46. Pregnancy in women with Cystic Fibrosis in the 21st century
47. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
48. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T−B− SCID in patients with defects in RAG genes
49. Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis
50. Factors Associated With Clinical Progression to Severe COVID-19 in People With Cystic Fibrosis: A Global Observational Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.